RecruitingPHASE2, PHASE3NCT06846385

Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis

Studying Polyrrhinia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanghai Mabgeek Biotech.Co.Ltd
Intervention
Placebo(biological)
Enrollment
160 target
Eligibility
18-75 years · All sexes
Timeline
20252025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06846385 on ClinicalTrials.gov

Other trials for Polyrrhinia

Additional recruiting or active studies for the same condition.

See all trials for Polyrrhinia

← Back to all trials